RIPK1 and Hypercholesterolemia: To examine the effect of RIPK1 inhibition on the development of advanced atherogenesis, we used a mouse model (ApoESA/SA) that exhibits both hypercholesterolemia and hypertension upon induction and develop advanced atherosclerotic lesions including those in coronary arteries (20).